Updated Jul 16, 2026
Curran Terrie has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $94K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-10 | ARQT | Arcutis Biotherapeutics, Inc. | A — Grant or award | 5.8K | $0.00 | |
| 2024-11-13 | ARQT | Arcutis Biotherapeutics, Inc. | S — Open-market sale | 8.7K | $10.85 | $94K |
Curran Terrie is a corporate insider — currently tracked as Director of Arcutis Biotherapeutics, Inc. (ARQT). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($94K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Curran Terrie profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.